Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

NCT00453570 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

792

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Haemophilus Influenzae Type b
Pertussis
Poliomyelitis

Interventions

BIOLOGICAL: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
BIOLOGICAL: Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
BIOLOGICAL: Diphtheria, Tetanus, & Acellular Pertussis Combined, Absorbed

Sponsor

Sanofi